Crockett Thomas Andrew 4

4 · KalVista Pharmaceuticals, Inc. · Filed Nov 1, 2023

Insider Transaction Report

Form 4
Period: 2023-10-30
Crockett Thomas Andrew
DirectorPresident and CEO
Transactions
  • Gift

    Common Stock

    2023-10-308,000138,756 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION